Since Lucentis cost much more than ILuvien, and Iluvien is as good or better in many cases I am told by medical professionals, then Genentech could enter bidding war for PSDV with Pfizer.This is in early bull phase of much bigger move and I added at $4.50. My humble opinion only
Add to My Watchlist
What is My Watchlist?